Skip to main content
Earnings Labs
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. (ACRS)

NASDAQ·Healthcare·Biotechnology

$3.92

+0.51%

Mkt Cap $531.39M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (10 analysts)

$10.75

Range $10.00 – $12.00

Implied Upside

+174.2%

Consensus $10.75 vs current $3.92